In human GBM cell lines, multiple simultaneous genomic alterations in TRAIL-R1, TRAIL-R2, caspase-8, Bid, and Smac loci were found to contribute to TRAIL resistance [62]. The gene discussed is CASP8; the disease is glioblastoma.